Announcements Trials
Browse Landscape

Phase

Phase NA 26Phase 1 9Phase 4 5Phase 2 4Phase 1/2 3Phase 3 2Phase EARLY_PHASE1 1

Status

Completed 3Unknown 1

Sponsor Class

OTHER 2NIH 1INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Sarcoma 1Gastrointestinal 1Endocrine 1CNS 1Breast 1

Conditions

Pancreatic Cyst 1Multiple Endocrine Neoplasia Type 1 1Gliosarcoma 1Glioblastoma 1Depression 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Alcoholism 1

Interventions

Cisplatin 1514Carboplatin 1416Cyclophosphamide 1359Gemcitabine 1235Bevacizumab 1223Paclitaxel 1210Radiotherapy 1173Docetaxel 1079pembrolizumab 1026Oxaliplatin 934Capecitabine 898Fluorouracil 832Rituximab 729Doxorubicin 683Nivolumab 679Dexamethasone 665Etoposide 660Irinotecan 622Leucovorin 574Pemetrexed 508Drug Therapy 491Cetuximab 481Trastuzumab 467Cytarabine 466Magnetic Resonance Spectroscopy 457Filgrastim 446Prednisone 432Lenalidomide 409Specimen Handling 407Temozolomide 400

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Phase 2 × Ethanol × Clear all
NCT01698918 2023-05-03

BOLERO-4

Novartis

Phase 2 Completed
202 enrolled 19 charts
Breast

Breast Neoplasms

NCT01475331 2018-03-20

The CHARM Trial: Chemotherapy for Ablation and Resolution of Mucinous Pancreatic Cysts

Milton S. Hershey Medical Center

Phase 2 Completed
46 enrolled 8 charts
Gastrointestinal

Pancreatic Cyst

NCT00006656 2013-11-06

Carmustine in Treating Patients With Progressive or Recurrent Glioblastoma Multiforme

National Cancer Institute (NCI)

Phase 2 Unknown
CNSSarcoma

Brain Neoplasms, Glioblastoma, Central Nervous System Neoplasms, Gliosarcoma

NCT00851669 2013-07-16

MEADOW/Bridge

University of Rochester

Phase 2 Completed
91 enrolled
Endocrine

Alcoholism, Depression, Multiple Endocrine Neoplasia Type 1

Data powered by HemOnc (CC BY 4.0) Colophon âš¡